Background Context Methamphetamine addiction has been recognized as a significant public health issue in the United States and internationally. In 2002, the
U.S. Department of Health and Human Services estimated 12 million people, age 12 and over, had used methamphetamine—600,000 of which were estimated to be current users—with a growth rate of approximately 300,000 new users per year. Research has documented specific health risks associated with methamphetamine use. In 2005, a Los Angeles clinic estimated that one out of three gay or bisexual HIV-positive men admitted to using methamphetamine.
Methamphetamine lowers a user's inhibitions, increasing the likelihood of engaging in
unprotected sex and
sharing needles. These public health concerns provided part of the context for CMA's founding and growth, particularly in communities significantly affected by methamphetamine use. While CMA has significant membership from the LGBTQ+ community, the fellowship serves anyone with a desire to stop using regardless of sexual orientation, gender-identity, race, religion, age, other personal identifiers.
CMA Membership Demographics The 2024 CMA Fellowship Survey gathered responses from 1,828 members representing 21 countries and 45 U.S. states, providing insight into the fellowship's composition. The 2024 Fellowship Survey respondents demonstrated diversity across age, gender identity, ethnicity, and sexual orientation, with a median age of 45 years. While CMA has significant membership from the LGBTQ+ community, the fellowship serves a diverse population across all sexual orientations and gender identities. ==Effectiveness==